 "Lupin")
Lupin Digital Health, a wholly-owned subsidiary of drug major Lupin, has launched its digital therapeutics solution Lyfe for cardiac patients in India as it aims to go beyond the pill and provide a support ecosystem for patients. The company aims to have one million users on-board Lyfe as it expands its offerings to include heart failure patients, hypertensive patients etc.
It is starting with acute coronary syndrome patients who have either recovered from a cardiac event, undergone an angioplasty or are at high risk of a cardiac event. Designed by Indian cardiologists, Lyfe helps patients improve heart health through doctor-connected
